News
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
20h
HealthDay on MSNADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With WaterFor adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
2d
MedPage Today on MSNMifepristone Helped Control Diabetes in Those With HypercortisolismCHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
20h
HealthDay on MSNADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 DiabetesThe oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...
A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...
A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes -- during a ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results